#ESHALL2023 THE PRELIMINARY PROGRAMME IS AVAILABLE

 

3rd Translational Research Conference

ACUTE LYMPHOBLASTIC LEUKAEMIA

 

Save the date: May 19-21, 2023

Berlin, Germany

#ESHALL2023

 

---

Take a first look at the preliminary programme of #ESHALL2023:

---

About the Conference:

Major recent advances in the knowledge of the biological underpinning of Acute Lymphoblastic Leukaemia (ALL) include the comprehensive description of B-cell precursor and T-cell ALL genomic landscapes, the identification of new potentially druggable disease subsets and the discovery of predisposing, preleukaemic events.

At the same time, the clinical management of the disease has improved in both children and adults thanks to the routine monitoring of measurable residual disease (MRD), the administration of intensified risk-adapted chemotherapy, the introduction of targeted therapies and antibodies, and the remarkable efficacy of antibody-drug conjugates (ADCs), bi-specific T-cell engager antibodies (BiTEs) and manufactured chimeric antigen receptor (CAR) T-cells.

This intense research activity has led to major improvements in patient outcome, while also providing important proofs of concept for the treatment of cancer in general. It has also made ALL a fascinating disease to study.

The translational scientific programme of the 3rd Translational Research Conference on Acute Lymphoblastic Leukaemia is designed to provide ample time and opportunities for discussion with global authorities in the field.

---

The programme will include:
Plenary Sessions - Panel Discussions - Debates
Poster Walks - Meet the Expert Sessions - Keynote lectures

For more information, click here!